by Dr. Jill Tieman
(GreenMedInfo) It is becoming more well known that poor digestion, leaky gut and dysbiosis can lead to health problems outside of the GI tract. In several previous articles I have discussed the effects of gluten on the brain as well as the effects of gluten on the cardiovascular system. In addition to these hazards, current research indicates a clear relationship between a mother’s sensitivity to gluten and the mental health of her child.
[Sponsor link: Stomach/Peptic Ulcer Healing Protocol]
In this study published in The American Journal of Psychiatry in June 2012, Swedish researchers investigated whether levels of Immunoglobulin G (IgG) — in particular those immunoglobulins directed at gluten — were associated with a later diagnosis of a non-affected psychotic disorder (like schizophrenia).
Immunoglobulin G
IgG immunogloblulins are the immune factors passed on to the newborn from the mother, predominately in the last month of pregnancy. They are derived from maternal circulation and transferred across the placenta. These factors respond to the immediate environment that the baby will be born into and will protect the baby from possible antigens such as the fur and hair of dogs and cats, as well as other potential environmental allergens.
Since they come directly from the mother’s circulation, high levels of particular IgG globulins are indicative of the mother’s reactivity to these substances. In this case, the IgG globulins studied were to gliadin — a component of gluten that can be measured in the blood.
The Swedish Medical Birth Register
In Sweden, records and blood samples from pregnant mothers have been kept since 1973 via The Swedish Medical Birth Register. This register includes information for all deliveries in Sweden as well as data from the prenatal and neonatal periods.
Blood is collected from all newborns as part of a screening program and kept at Karolinska University Hospital. When a person consents to it, researchers can locate the blood spot and use it for study, as they did here.
The investigators choose a population of babies born between 1975 and 1985 with verified register-based diagnoses of non-affective psychoses made as in-patients between 1987 and 2003 and as out-patients between 1997 and 2003. They compared these to subjects without non-affective psychoses, of similar sex, dates of birth, birth hospital and municipality, among other details, for a total of 211 case studies and 553 comparison studies.
The researchers analyzed the levels of IgG antibodies to gliadin (an active component of gluten) and also casein (milk protein). In this study there was no relationship found between the casein antibodies and psychoses.
The Results May Astound You
The scientists found that mothers in the group with the top 10% of anti-gliadin antibodies had offspring with over a 70% likelihood to develop schizophrenia later in life. Mothers in the group with the top 5% of anti-gliadin antibodies had offspring with a whopping 240% chance of developing schizophrenia as an adult.
It goes without saying that there is a relationship here that needs further investigation and more widespread understanding in order for it to become protocol to test women of child bearing age for these antibodies before they become pregnant.
It has been shown is this study published in Human Reproduction in 2010 that untreated celiac disease in the mother increases the risk for adverse pregnancy outcomes such as low birth weight, intrauterine growth restriction, and prematurity.
Celiac disease and risk of adverse fetal outcome: a population-based cohort study, published in Gastroenterology in 2005 also showed that undiagnosed maternal celiac disease is a risk factor for unfavorable fetal outcomes, but the risks are reduced when celiac disease has been diagnosed and can be treated with a gluten-free diet. The unfavorable outcomes referred to, intrauterine growth retardation, low birth weight (<2500 g), very low birth weight (<1500 g), preterm birth (<37 gestational weeks), very preterm birth (<30 gestational weeks), and Caesarean section. The mothers who received the diagnosis of celiac disease before birth was not associated with these adverse fetal outcomes.
Clearly, once the diagnosis of celiac disease is made, the quick and simple action of a gluten-free diet may be taken to improve the health of the mother and the developing baby.
As published in the American Journal of Gastroenterology in 1999, Khashan et al found that the offspring of mothers with celiac disease had lower birth weight than expected and more than a three-fold higher risk of intrauterine growth retardation when birth occurred before the first hospitalization for the disease. They conclude that treatment of celiac women is important in the prevention of fetal growth retardation.